Viewing nowAtovazin 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 201906438 · Approved 2019.09.11 · Insurance code 642405180
Improvement of hyperlipidemia (including familial hypercholesterolemia in children) and prevention of cardiovascular disease (e.g., myocardial infarction)
This medication helps reduce the risk of cardiovascular diseases and aids in the treatment of hyperlipidemia. Specifically, it decreases the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. It also contributes to protecting heart health by reducing the risk of non-fatal myocardial infarction, stroke, angina, and hospitalization for congestive heart failure in patients with clinical evidence. Regarding hyperlipidemia, it improves lipid levels in patients with primary and mixed dyslipidemia, dysbetalipoproteinemia, and hypertriglyceridemia, thereby reducing the burden of cardiovascular disease. Particularly, it is used as an adjunct to diet in children aged 10 to 17 years with heterozygous familial hypercholesterolemia. Overall, this medication is used to enhance health through the prevention of cardiovascular diseases and improvement of blood lipid levels.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medication may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction of 45 % or more in LDL cholesterol is required). This medication is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to patient characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing response. However, when LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia: This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are unavailable. Patients with renal impairment: No dose adjustment is necessary, as renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect. Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses greater than 20 mg of this medication in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause unusual symptoms in the muscles, so if severe muscle pain or weakness occurs, or if creatine kinase levels significantly rise, discontinue use immediately and consult a doctor. This medication may affect liver function, so patients with active liver disease or abnormally high liver enzyme levels should not use it. Patients with a history of muscle disease or poor kidney function should use this medication with caution and may require regular testing. Women who are pregnant or may become pregnant, and breastfeeding women should not take this medication and should use appropriate contraceptive methods while on this medication. This medication should not be used by children, especially those under 10 years of age, and its long-term safety has not been established in children over 10. If taken with certain specific medications, drug concentrations may increase, raising the risk of side effects, so it is essential to inform your doctor or pharmacist of any other medications being taken. There is no specific antidote for overdose, and treatment should be based on symptoms, with monitoring of liver function and muscle enzyme levels. This medication should be stored out of reach of children and kept in its original container for safety. It is important to notify healthcare professionals immediately if symptoms such as muscle pain, weakness, or fever occur during this medication regimen and to seek testing. Regular liver function tests and monitoring of muscle condition are necessary with long-term use, and if any abnormal symptoms arise, the medication should be discontinued immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is best to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature. Doing so will help retain the medication's efficacy and safety over time.
White, round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.